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Rheumatology, Queen Mary University of London, London, UKC3 glomerulopathy is a complement-mediated renal
disease that is frequently associated with abnormalities in
regulation of the complement alternative pathway. Mice
with deﬁciency of factor H (Cfh–/–), a negative alternative
pathway regulator, are an established experimental model
of C3 glomerulopathy in which complement C3 fragments
including iC3b accumulate along the glomerular basement
membrane. Here we show that deﬁciency of complement
receptor 3 (CR3), the main receptor for iC3b, enhances the
severity of spontaneous renal disease in Cfh–/– mice. This
effect was found to be dependent on CR3 expression on
bone marrow–derived cells. CR3 also mediated renal
protection outside the setting of factor H deﬁciency, as
shown by the development of enhanced renal injury in
CR3-deﬁcient mice during accelerated nephrotoxic
nephritis. The iC3b–CR3 interaction downregulated the
proinﬂammatory cytokine response of both murine and
human macrophages to lipopolysaccharide stimulation
in vitro, suggesting that the protective effect of CR3 on
glomerular injury was mediated via modulation of
macrophage-derived proinﬂammatory cytokines. Thus, CR3
has a protective role in glomerulonephritis and suggests
that pharmacologic potentiation of the macrophage CR3
interaction with iC3b could be therapeutically beneﬁcial.
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Kidney International (2016) 89, 823–832C 3 glomerulopathy (C3G) is a category of kidney dis-eases that includes dense-deposit disease, C3 glomeru-lonephritis, and complement factor H–related protein
5 (CFHR5) nephropathy.1 C3G is deﬁned by the presence
of isolated or dominant complement C3 within the glomer-
ulus. It is frequently due to uncontrolled C3 activation via
the complement alternative pathway, which may be genetic
or acquired. Causes include deﬁciency or dysfunction of fac-
tor H (FH), the major plasma alternative pathway regulatory
protein. Progression to end-stage kidney disease occurs in
w40% of patients after 10 years, and recurrence after renal
transplantation is common. At present, there is no proven
treatment for C3G, although the C5 inhibitor eculizumab
may have a role based on a small prospective trial and several
case reports.2
Mice with homozygous deﬁciency of FH (Cfh–/–) have
proved to be an informative experimental model of C3G.3
Cfh–/– mice spontaneously develop low plasma C3 and C5
levels and linear staining of C3 and C9 along the glomerular
basement membrane (GBM). The development of glomerular
C3 deposition is absolutely dependent on activation of C3
through the alternative pathway.3 Complement C3 along the
GBM in these animals includes iC3b, a cleavage product of
C3b.4,5 Complement receptor 3 (CR3), also known as Mac-1
(CD11b/CD18, aMb2), is the main leukocyte receptor for
iC3b.6,7 CR3 is a b2–integrin receptor expressed mainly on
neutrophils, monocytes and macrophages, and dendritic
cells.8 The a-chain (CD11b), encoded by the ITGAM gene,
confers binding of CR3 to a wide range of endogenous and
pathogen-derived ligands. CR3 mediates diverse cellular
functions including phagocytosis of iC3b-coated particles,
cytotoxicity, chemotaxis, and cell adhesion,9 which play a
critical role in regulating inﬂammation and antimicrobial
immunity. In vitro and in vivo observations have also revealed
a role for CR3 in toll-like receptor (TLR)–triggered innate
immune responses, but the nature of this cross-talk remains
controversial, with some studies demonstrating that CR3 can
promote TLR-induced inﬂammation,10–12 whereas others
have reported negative roles for this integrin in TLR
responses.13,14
CR3 has been implicated in the pathophysiology of
glomerulonephritis (GN). An allelic variant of ITGAM is a
risk factor for systemic lupus erythematosus, including renal
manifestations.15 Experiments in mice with homozygous
deﬁciency of CR3 (Itgam–/–) have shown a deleterious role for823
bas i c re sea r ch TD Barbour et al.: Complement receptor 3 and C3 glomerulopathyCR3 in acute glomerular injury such as the heterologous
nephrotoxic nephritis (NTN) model.16,17 In contrast, a pro-
tective role for CR3 was demonstrated in experimentally
triggered immune complex GN.18,19 These differences have
been attributed to “context-dependent” immune effects of
CR3.19
The contribution of CR3 to the spontaneous renal pa-
thology associated with FH deﬁciency is unknown. We
investigated the effect of CR3 on the renal phenotype of Cfh–/–
mice by intercrossing these animals with the Itgam–/– strain.
We observed that CR3 deﬁciency exacerbated spontaneous
renal disease associated with complete FH deﬁciency and that
this was dependent on the expression of CR3 on bone
marrow (BM)–derived cells. We also observed that the
Itgam–/– strain were more susceptible to renal damage during
accelerated NTN (ANTN). The in vitro stimulation of CR3
with iC3b-coated targets limited the proinﬂammatory cyto-
kine proﬁle triggered by lipopolysaccharide (LPS) in murine
and human macrophages. In contrast, cytokine secretion was
enhanced in neutrophils, indicating that the modulating ef-
fects of CR3 differ between monocytes/macrophages and
neutrophils. Together our data indicate that strategies to
promote the interaction of CR3 with iC3b and other potential
ligands in the kidney may be a suitable therapeutic goal in
C3G.a
c
0
100
200
300
400
P
la
sm
a 
C
3 
–
m
ic
ro
gr
am
s 
pe
r m
l
Cfh-/-.Itgam-/- Cfh-/- Itgam-/-
P = 0.011
P = 0.004
Cfh-/-.Itgam-/-
Figure 1 | Plasma and glomerular C3 in mice with combined deﬁcie
levels (a) and glomerular C3 staining intensity (b) in 8-month-old Cfh–/–
conditions. Horizontal bars denote median values. AFU, arbitrary ﬂuoresc
in the 3 genotypes. Bar ¼ 80 mm. Each symbol represents a mouse. P v
824RESULTS
CR3 deﬁciency exacerbates spontaneous C3G in Cfh–/– mice
The role of CR3 in experimental spontaneous C3G was
assessed by generating mice with combined deﬁciency of FH
and CR3 (Cfh–/–.Itgam–/–). Cohorts of female Cfh–/–.Itgam–/–
(n ¼ 10) and Cfh–/– (n ¼ 5) mice were monitored in speciﬁc
pathogen–free (SPF) conditions for 8 months. While plasma
and glomerular C3 remained normal in Itgam–/– mice,
Cfh–/–.Itgam–/– animals developed low plasma C3 and
abnormal GBM C3 accumulation comparable to that seen in
Cfh–/– animals (Figure 1). However, Cfh–/–.Itgam–/– animals
developed greater renal inﬂammation at 8 months (Table 1).
At this time point albuminuria was signiﬁcantly increased in
Cfh–/–.Itgam–/– compared to Cfh–/– mice (median 173.2 mg/16
h, range 72.5–987.2, vs. 74.8 mg/16 h, range 33.8–141.2, P ¼
0.028, Mann-Whitney test) together with greater glomerular
cell counts (Table 1). A single Cfh–/–.Itgam–/– mouse devel-
oped hematuria and distress necessitating killing at 6 months.
In this mouse only, diffuse crescentic GN was evident on light
microscopy. In a second cohort of female Cfh–/–.Itgam–/– (n ¼
12) and Cfh–/– (n ¼ 12) mice housed in non-SPF conditions
over an 8-month period, we noted signiﬁcantly reduced
survival in Cfh–/–.Itgam–/– animals (Table 1). Renal histology
was not available from the 6 Cfh–/–.Itgam–/– animals that died
prior to the 8-month time point. Of the 6 Cfh–/–.Itgam–/–b
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Table 1 | Spontaneous renal disease in FH-deﬁcient mice with or without CR3
Speciﬁc pathogen–free conditions Non–speciﬁc pathogen–free conditions
Genotype Cfh–/–.Itgam–/– Cfh–/– Cfh–/–.Itgam–/– Cfh–/–
Mice, number/sex 10/F 5/F 12/F 12/F
Survival at 8 months, % (number) 90% (9) 100% (5) 50% (6)c 100% (12)
Plasma urea, median mmol/l (range) 13.3 (9.8–44.5) 11.5 (7.3–15.1) 13.5 (10.1–39.2)d 12.9 (9.7–25.7)
Glomerular cell count, median (range) 53.4 (40.8–75.9)a 36.6 (34.9–44.4) 44.2 (39.2–61.7)d 41.7 (35.9–56.1)
Glomerular macrophage count, median (range) 4.3 (0.9–9.9) 1.9 (1.2–3.1) 8.5 (5.1–14.5)b,d 3.7 (0.9–11.0)
F, female.
aP ¼ 0.003.
bP ¼ 0.0007, Mann-Whitney Test.
cP ¼ 0.006, log-rank test.
dData refer to the 6 mice that were culled at the 8-month time point.
TD Barbour et al.: Complement receptor 3 and C3 glomerulopathy ba s i c re sea r chanimals culled at the 8-month time point, hematuria and
albuminuria were present in 4. Glomerular cellularity was
similar between the Cfh–/– and Cfh–/–.Itgam–/– groups, but the
number of glomerular macrophages was signiﬁcantly
increased in the Cfh–/–.Itgam–/– mice (Table 1). These data
indicated that CR3 deﬁciency increased mortality and spon-
taneous glomerular inﬂammation associated with FH deﬁ-
ciency and that the size of this effect was inﬂuenced by the
environmental conditions. We next determined whether CR3
on BM-derived cells was responsible for this effect.
Lack of CR3 expression on BM-derived cells exacerbates
spontaneous C3G in Cfh–/– mice
Three groups of irradiated Cfh–/– mice were reconstituted
with Itgam–/– (n ¼ 8), wild-type (n ¼ 7), or Cfh–/– (n ¼ 9)
BM-derived cells. At 8 months, Cfh–/– recipients of Itgam–/–
BM-derived cells showed signiﬁcantly increased plasma urea,
glomerular cellularity, and glomerular macrophage counts
(Figure 2). Notably, renal parameters between recipients of
wild-type and Cfh–/– BM-derived cells did not differ. These
data suggested that the deleterious effect of CR3 deﬁciency on
the renal disease associated with FH deﬁciency was mediated
by the lack of CR3 expression on BM-derived rather than
intrinsic renal cells. We next explored the effects of CR3a b
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Figure 2 | Bone marrow transplantation in factor H (FH)–deﬁcient mice
marrow (BM)–derived cells isolated from Itgam–/–, wild-type, or Cfh–/–mice an
urea (a), glomerular cellularity score (b), and glomerular macrophage score
BM-derived cells. Horizontal bars denote median values. Each symbol repre
Kidney International (2016) 89, 823–832deﬁciency on experimental renal disease independent of FH
deﬁciency.
Itgam–/– mice are more susceptible to ANTN
Itgam–/– mice showed no evidence of an abnormal sponta-
neous renal phenotype at 8 months in either SPF (n ¼ 6F) or
non-SPF (n ¼ 10F) conditions. Speciﬁcally, hematuria did
not develop in these animals, and glomerular histology at
8 months by light microscopy was normal (data not shown).
We then speculated that CR3 deﬁciency could inﬂuence the
response of the kidney during experimentally triggered renal
inﬂammation. To investigate this we performed ANTN in
Itgam–/– (n ¼ 8) and wild-type (n ¼ 10) mice. Two days after
injection of nephrotoxic serum, hematuria was detectable in 7
of the 8 Itgam–/– mice but absent in all wild-type animals. Ten
days after administration of nephrotoxic serum, when all
animals were culled, the Itgam–/– mice had signiﬁcantly
greater hematuria, plasma urea levels, and glomerular cres-
cents (Figure 3). Glomerular macrophage counts were no
different between groups. Glomerular deposition of sheep
and mouse IgG and antigen-speciﬁc plasma titers of mouse
IgG did not differ between the groups (data not shown).
These data indicated that CR3 deﬁciency exacerbated renal
injury during ANTN.Cfh-/-
wild-type
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Figure 3 | Accelerated serum nephrotoxic nephritis in complement receptor 3–deﬁcient mice. (a–c) Hematuria (a), plasma urea (b), and
glomerular crescent score (c) were signiﬁcantly increased at day 10 in Itgam–/– mice. One point is missing from the Itgam–/– glomerular crescent
data set due to loss of a sample. (d) Glomerular macrophage numbers, determined by CD68 reactivity, did not differ between Itgam–/– and wild-
type mice. Horizontal bars denote median values. Each symbol represents a mouse. P values derived from Mann-Whitney test. (e) Represen-
tative light microscopic images from Itgam–/– and wild-type mice of glomeruli stained using periodic acid–Schiff reagent. A circumferential
crescent is evident in the Itgam–/– section, while the wild-type glomerulus appears normal. Bar ¼ 80 mm.
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cytokine release
Since iC3b is abundantly present within the glomerulus in
experimental C3G and complement is activated during
ANTN, we hypothesized that the interaction between iC3b
and CR3 on myeloid cells within the kidney resulted in an
anti-inﬂammatory response that in turn reduced the severity
of the renal injury. To investigate this we assessed the effect of
iC3b-coated guinea pig red blood cells (gRBCs) on LPS-
induced cytokine secretion by murine myeloid cells (both
monocytes and macrophages at day 2 and day 7 of differen-
tiation in vitro). Preincubation with iC3b-gRBCs resulted in
reduced secretion of interleukin-6 (IL-6), but enhanced
secretion of IL-10 (Figure 4). These cytokine changes were
CR3-dependent since they were not observed when we used
macrophages from Itgam–/– mice (Supplementary Figure S1A
online). We then examined human cells preincubated with
iC3b-coated beads (Figure 5). We initially noticed that human
monocyte-derived macrophages display a progressive loss of826CD11b expression during differentiation in vitro, most likely
due to adherence to plastic. By day 7, the expression of
CD11b, including its active form assessed with the CBRM1/5
antibody, was barely detectable (Supplementary Figure S1B).
Therefore, we chose to study monocytes and monocyte-
derived macrophages at day 2 only. In both cell types iC3b
pre-ligation downmodulated the proinﬂammatory cytokine
proﬁle triggered by LPS and promoted an anti-inﬂammatory
response (Figure 5). In contrast, the cytokine effect of iC3b-
coated beads on TLR4-stimulated neutrophils was proin-
ﬂammatory with signiﬁcantly increased production of IL-8
and CCL3 (MIP-1a). These cytokine effects were observed
regardless of whether the cells were exposed to iC3b-coated
beads before, simultaneously, or 1 hour after LPS challenge
(data not shown). We also analyzed cytokine production after
overnight stimulation with iC3b-coated particles alone or
medium alone. Neither of these conditions induced detectable
cytokines, demonstrating no endotoxin contamination (data
not shown). Taken together these data demonstrate that theKidney International (2016) 89, 823–832
Monocytes  
Day 2 Macrophages  
Day 7 Macrophages  
400 40
0
50
100
150
200
300
400
20
10
0
30
300
200
600
800
200
0
400
4000
6000
2000
0
P = 0.0039
P = 0.0217
P = 0.03
P = 0.02
 P = 0.0145
pg
/m
l
pg
/m
l
pg
/m
l
pg
/m
l
pg
/m
l
pg
/m
l
LPS
iC3b/LPS
NS
IL-10
IL-10
IL-6
IL-6
IL-10IL-6
Figure 4 | Modulation of TLR4-induced cytokine release by iC3b-guinea pig red blood cells (gRBCs).Murine monocytes (n ¼ 3) (top), day 2
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IL-10 in the samples with and without CR3 pre-engagement are shown with the P values indicated. Data are expressed as mean  SEM, paired
t-test. The data are representative of 3 independent experiments.
TD Barbour et al.: Complement receptor 3 and C3 glomerulopathy ba s i c re sea r chcytokine modulating effects mediated by CR3 through the
binding of iC3b are distinct and cell type–speciﬁc.
DISCUSSION
Progressive renal disease in Cfh–/– mice is associated with
accumulation of C3 activation fragments including iC3b
along the GBM. Here we show increased severity of the
spontaneous glomerular phenotype in 8-month-old Cfh–/–
mice with coexisting deﬁciency of CR3, the leukocyte receptorKidney International (2016) 89, 823–832for iC3b. Disease exacerbation was more marked in non-SPF
compared to SPF housing conditions. This protective effect
was dependent on CR3 expression on BM-derived cells.
Glomerular macrophages were increased in Cfh–/– animals
reconstituted with Itgam–/– BM-derived cells, suggesting that
these macrophages were contributing to the protective effect.
In order to determine whether CR3-dependent glomerular
protection also occurred outside the setting of FH deﬁciency,
we investigated the response of Itgam–/– mice to ANTN. Early827
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bas i c re sea r ch TD Barbour et al.: Complement receptor 3 and C3 glomerulopathyhematuria developed exclusively in Itgam–/– mice, persisting
until day 10 when these animals had evidence of severe renal
injury with crescentic GN. These observations indicated that
CR3 mediated a protective effect during subacute renal828inﬂammation, that is, at a time when macrophages are pre-
sent within the glomeruli.
CR3-mediated signaling is usually viewed as proin-
ﬂammatory, and prevention of CR3–iC3b interaction byKidney International (2016) 89, 823–832
TD Barbour et al.: Complement receptor 3 and C3 glomerulopathy ba s i c re sea r chantibody or genetic deletion has been shown to decrease the
severity of inﬂammatory responses in several animal models
including heterologous NTN.16,17 Hence the ﬁndings that
CR3 provided a beneﬁcial effect in our spontaneous model of
C3G in Cfh–/– mice were unexpected, and suggest that stra-
tegies to block CR3-dependent inﬂammation may not be
beneﬁcial as previously thought. An explanation for the
contradictory role of CR3 in various disease models10,20–22
may lie in the predominant role played by the different
innate or adaptive immune cells in these experimental con-
ditions and the fact that CR3 operates in a cell type–speciﬁc
manner. Similarly, previous data in C3-deﬁcient mice
demonstrated that C3 contributed to renal injury in the acute
phase of heterologous NTN.23 However, C3-deﬁcient animals
developed greater renal injury during the autologous phase of
heterologous NTN. In the same study C3 deﬁciency was also
associated with exacerbation of renal injury in ANTN. We
speculated that in our model of spontaneous renal pathology
associated with FH deﬁciency the renal protective effect was
mediated by an interaction between iC3b and CR3 on BM-
derived macrophages. We therefore examined the CR3-
dependent cytokine responses of myeloid cells to iC3b-
coated targets. We studied the macrophage cytokine
response to TLR4 ligation, which plays a deleterious role in
several models of GN, including ANTN.24 Here, we found
that the interaction of iC3b with CR3 on both murine and
human monocytes and macrophages is associated with an
enhanced anti-inﬂammatory cytokine proﬁle (reduced IL-6
and increased IL-10 secretion) following LPS stimulation.
These data are consistent with earlier studies indicating that
engagement of CR3 inhibited secretion of proinﬂammatory
cytokines by TLR4-stimulated monocytes and macro-
phages.10,25–27 Pre-ligation with a synthetic CD11b agonist
has also been shown to inhibit human macrophage secretion
of tumor necrosis factor-a in response to synthetic TLR7/8
ligands.28 Our data showing an anti-inﬂammatory effect due
to iC3b ligation of CR3 on macrophages are also consistent
with earlier studies showing downregulation of proin-
ﬂammatory cytokines during phagocytosis of complement-
opsonized apoptotic cells.29,30 In addition, our data support
the notion that the cytokine modulating effects of the iC3b–
CR3 interaction are cell type–speciﬁc, since the effect on
human neutrophils was proinﬂammatory. This opposite
response mediated by CR3 to LPS stimulation may explain
the conﬂicting results in the literature, including the delete-
rious role of CR3 in heterologous NTN, since this model
mainly depends on the initial glomerular neutrophil
inﬂux.16,17
Additional immune mechanisms may have contributed to
our ﬁnding of CR3-mediated protection in the ANTN model.
Firstly, ANTN has been extensively characterized in C57BL/6
mice as involving a T helper 1–predominant, delayed-type
hypersensitivity–like nephritogenic immune response.31
T helper 17–directed cellular immune responses have also
been implicated in several murine models of crescentic
nephritis, including ANTN.32 Both enhanced delayed-typeKidney International (2016) 89, 823–832hypersensitivity and T helper 17 immune differentiation
have previously been demonstrated in Itgam–/– mice using a
model of low-dose oral antigen (ovalbumin) exposure fol-
lowed by high-dose immunization with antigen and complete
Freund’s adjuvant (CFA).21 Secondly, CR3 may negatively
regulate CFA-induced proinﬂammatory signaling, with renal
injury in the ANTN model being dependent on the sensiti-
zation phase induced by IgG mixed with CFA. CFA is a
recognized TLR agonist,33,34 and increased renal injury due to
TLR4 ligation speciﬁcally during sensitization has been
demonstrated in ANTN studies.24 A protective role for CR3
was also reported in a passive transfer model of GN in lupus-
prone (New Zealand black  New Zealand white)F1 with se-
lective neutrophil transgenic expression of human FcgRIIA or
FcgRIIA and FcgRIIIB.19 Again this model relied on a
CFA-based protocol. In addition, CFA can induce a CD11b-
positive splenic cell population with immunosuppressive
effects on T cell–mediated immunity,11,35 and this could also
play an important role. Notably, these immune mechanisms do
not appear to be implicated in the spontaneous GN occurring
in systemic lupus erythematosus–prone MRL/MpJ-FASlpr
mice, in which CR3 deﬁciency made no difference to the
severity of the renal pathology.36
A recent study suggested that CR3 is a negative regulator of
B-cell receptor signaling, based on experiments in anti-
snRNP Ig transgenic mice.37 In our study we found that
CR3 deﬁciency did not inﬂuence the antigen-speciﬁc IgG
response following administration of nephrotoxic serum in
sensitized (ANTN) mice, making an impaired antibody
response an unlikely explanation for the protective effect
mediated by CR3. Another study utilized the chronic serum
sickness model of immune complex GN, in which mice were
injected with horse spleen apoferritin.18 In that study,
increased severity of proliferative GN in Cfh–/– mice receiving
an Itgam–/– BM transplant, compared to Cfh–/– recipients of
either a wild-type or Cfh–/– BM, correlated with an increased
anti-apoferritin IgG immune response. However, chronic
serum sickness without BM transplantation did not produce
proliferative GN in Itgam–/– mice (notwithstanding signiﬁ-
cantly increased albuminuria compared to wild-type mice),
with no differences in the anti-apoferritin IgG immune
response between the Itgam–/– and wild-type groups. Notably,
both previous studies18,37 utilized repeated antigen dose
administration (without adjuvant) over a long period, which
is a different approach for eliciting IgG immune responses
from the one used in our study.
We have shown that CR3 mediates renal protection in vivo
during both spontaneous C3G and ANTN. In our model of
experimental C3G, the interaction between the abundant
iC3b along the GBM with CR3 expressed on macrophages
appears to result in the downregulation of the proin-
ﬂammatory cytokine response by macrophages. Mechanisms
of renal injury in C3G include C3- and C5-dependent effector
functions. Our data indicate that the iC3b–CR3 interaction
does not contribute to renal injury. In contrast, this interac-
tion is protective. Potentiating the macrophage CR3–iC3b829
bas i c re sea r ch TD Barbour et al.: Complement receptor 3 and C3 glomerulopathyinteraction could therefore be beneﬁcial in the treatment of
C3G. Preclinical evaluation of small-molecule CR3 agonists
has produced promising results in a number of animal
models of glomerular disease including heterologous NTN.38
In summary, our data contribute to our mechanistic under-
standing of C3G and demonstrate that the anti-inﬂammatory
consequences of the macrophage CR3–iC3b interaction result
in reduced renal injury.MATERIALS AND METHODS
Mice
C57BL/6 wild-type mice were purchased from Harlan Ltd. (Bicester,
UK) and CR3-deﬁcient (Itgam–/–) mice39 from Jackson Laboratory
(Bar Harbor, ME). FH-deﬁcient (Cfh–/–) mice3 and Itgam–/– were
backcrossed onto a C57BL/6 genetic background for 10 generations.
Cfh–/–.Itgam–/– mice were generated by intercrossing the Cfh–/– and
Itgam–/– strains. All animal procedures were performed in accor-
dance with institutional guidelines and under license by the UK
government.
Accelerated NTN and BM transplantation
Accelerated NTN (ANTN) was induced by the i.v. injection of 200
ml of sheep nephrotoxic serum (a sheep Ig fraction containing
anti-mouse GBM antibodies) into mice that had been sensitized
with an intraperitoneal injection of 200 mg of sheep IgG (Sigma-
Aldrich, Dorset, UK) in CFA (Sigma-Aldrich) as previously
described.3 BM transplantation was performed as previously
described.40 Brieﬂy, mice were irradiated at 8 Gy using a 137Cs
g-ray source and reconstituted with 107 BM-derived cells from
donor strains. Mice were housed in SPF conditions and individ-
ually ventilated cages.
Assessment of renal function, plasma C3, and immune
response to sheep IgG
Dipstick hematuria was detected using Hema Combistix urine re-
agent strips (Siemens, Frimley, UK). Albuminuria was measured
using radial immunodiffusion with a rabbit anti-mouse albumin
antibody (product no. 0220-1829, AbD Serotec, Oxford, UK) and
puriﬁed mouse albumin standard (Sigma-Aldrich) as previously
described.41 Mouse blood samples were collected directly into eth-
ylenediamine tetraacetic acid–containing Eppendorf tubes and kept
on ice until centrifugation and stored as single-use aliquots at –80 C.
Plasma urea was measured using an ultraviolet method according
to the manufacturer’s instructions (R-Biopharm, Glasgow, UK).
Measurement of plasma C3 was performed by enzyme-linked
immunosorbent assay (ELISA) as previously described41 using un-
conjugated polyclonal goat anti-mouse C3 capture antibody (prod-
uct no. 0855463, MP Biomedicals, Cambridge, UK) and horseradish
peroxidase–conjugated polyclonal goat anti-mouse C3 detecting
antibody (product no. 0855557, MP Biomedicals). A standard curve
was generated using acute-phase serum containing a known quantity
of C3 (Calbiochem, Hertfordshire, UK). The mouse IgG anti-sheep
IgG response was assessed by ELISA. Microtiter plates were coated
with 3.5 mg/ml sheep IgG (Sigma-Aldrich), plasma samples added at
doubling dilutions, and bound mouse IgG detected using a poly-
clonal sheep horseradish peroxidase–conjugated anti-mouse IgG
antibody (product no. 515-035-062, Jackson ImmunoResearch
Laboratories, West Grove, PA) and TMB substrate (BD Biosciences,
Franklin Lakes, NJ).830Histologic studies
Mouse kidneys were ﬁxed in Bouin’s solution (Sigma-Aldrich),
embedded in parafﬁn, and sections stained with periodic acid–Schiff
reagent. Ten to twenty glomeruli per section were scored for total
cells, crescents, and macrophages using light microscopy. Macro-
phages were identiﬁed by anti-CD68 antibody reactivity in either (i)
acetone-dried frozen sections using Alexa Fluor 488–conjugated
monoclonal rat anti-mouse CD68 (product no. 137012, BioLegend,
San Diego, CA) to directly identify macrophages and biotinylated
goat anti-peanut agglutinin polyclonal antibody (product no. BA-
0074, Vector Laboratories, Burlingame, CA) with Alexa Fluor 555–
conjugated streptavidin (product no. S-21381, Invitrogen, Carlsbad,
CA) to identify non-glomerular structures; or (ii) frozen sections
from renal tissue ﬁxed in periodate lysine paraformaldehyde, washed
overnight in 7% sucrose in phosphate-buffered saline (PBS) and
frozen in isopentane precooled with liquid nitrogen using FA11
(monoclonal rat anti-mouse CD68, Serotec, Oxford, UK), polyclonal
mouse anti-rat IgG, and rat peroxidase–anti-peroxidase applied
sequentially (both from Jackson ImmunoResearch Laboratories).42
The slides were developed in diaminobenzidine and counterstained
with hematoxylin (Sigma-Aldrich). Quantitative renal immuno-
staining for mouse C3, mouse IgG, and sheep IgG was performed on
acetone-dried frozen renal sections using ﬂuorescein isothiocyanate
(FITC)–conjugated polyclonal goat anti-mouse C3 (product no.
0855500, MP Biomedicals, Solon, OH), FITC-conjugated polyclonal
goat anti-mouse IgG Fc (product no. F5387, Sigma-Aldrich, St.
Louis, MO), and FITC-conjugated monoclonal mouse anti-goat/
sheep IgG (product no. F4891, Sigma-Aldrich, St. Louis, MO) an-
tibodies as previously described.43
Human and mouse cell isolation
Peripheral blood samples were obtained by venipuncture of healthy
adult volunteers after informed written consent was obtained in
accordance with the Declaration of Helsinki. Samples were collected
as a subcollection registered with the Imperial College Healthcare
Tissue Bank (NRES approval 12/WA/0196). Human neutrophils
were isolated by dextran sedimentation and discontinuous plasma–
OptiPrep gradients followed by negative selection using a custom
antibody cocktail as previously described.11,27 Monocytes were ob-
tained by density gradient separation coupled with a negative se-
lection kit for human monocytes as recommended by the
manufacturer (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany).
Monocyte-derived macrophages were generated by culturing the
cells for 2 days in RPMI-1640 medium supplemented with 10% fetal
calf serum, 2 mM L-glutamine, 1% penicillin/streptomycin (Thermo
Fisher Scientiﬁc, Waltham, MA), and 20 ng/ml recombinant human
macrophage colony-stimulating factor (PeproTech, Rocky Hill, NJ)
as described previously.44 Murine monocytes were puriﬁed from
peripheral mouse blood with EasySep Mouse Monocyte Enrichment
Kit (Stemcell Technologies, Vancouver, BC, Canada). Macrophages
were generated by culturing murine monocytes with 20 ng/ml re-
combinant human macrophage colony-stimulating factor (Pepro-
Tech) for 2 or 7 days.
Flow cytometry
Murine and human leukocytes were stained using standard protocols
in the presence of a saturating concentration of 2.4G2 monoclonal
antibody (anti-CD16/32). The following antibodies were used:
phycoerythrin-conjugated anti-mouse/human CD11b (M1-70,
product no. 12-0112, eBioscience, San Diego, CA) and
phycoerythrin-conjugated anti-human CD11b (active epitope,Kidney International (2016) 89, 823–832
TD Barbour et al.: Complement receptor 3 and C3 glomerulopathy ba s i c re sea r chCBRM1/5, product no. 12-0113, eBioscience). Data were acquired
using a FACSCalibur (Becton Dickinson, Franklin Lakes, NJ) and
analyzed using FlowJo software, version 7.6 (Tree Star, Ashland, OR).
Cytokine assays
The cytokine assays were performed using human and mouse cells
and 2 types of iC3b-coated particles: guinea pig red blood cells
(gRBCs) for murine cells and Fluoresbrite carboxylate YG 1.5-mm
microspheres (Polysciences Inc., Warrington, PA) for human cells.
gRBCs (TCS Biosciences, Buckingham, UK) were opsonized with
mouse C5-deﬁcient serum at 37 C for 30 minutes, resuspended to
1% vol/vol in culture medium, and added to mouse cells at a 10:1
ratio (gRBCs/cells). Fluoresbrite carboxylate microspheres were
resuspended (1/200) in Krebs-Ringer PBS-Glucose buffer with hu-
man iC3b (20 mg/ml, Complement Technology Inc., Tyler, TX) and
incubated at 37 C for 30 minutes. Human iC3b–coated beads were
then washed with PBS plus 1% bovine serum albumin plus ethyl-
enediamine tetraacetic acid and resuspended in culture medium (1/
400). For both iC3b-coated targets the level of iC3b opsonization was
checked by ﬂow cytometry using a biotinylated polyclonal antibody
that recognizes both human and mouse C3 fragments (clone: 6C9,
product no. CL7631B, Cedarlane Laboratories, Burlington, ON,
Canada) followed by streptavidin-phycoerythrin (BD Biosciences
Pharmingen). In each assay, neutrophils (2  105 cells per well),
monocytes (2  105 cells per well), or macrophages (1  105 cells
per well) were preincubated for 1 hour at 37 C with iC3b-coated
targets and then stimulated with LPS 10 ng/ml (TLR grade R515,
Enzo Life Sciences, Lausen, Switzerland). Cells incubated with iC3b-
coated particles or medium alone were used as controls. Superna-
tants were collected after 24 hours and frozen until analysis. Human
cytokine levels (IL-1b, IL-6, IL-10, tumor necrosis factor-a, IL-8, and
CCL3) were measured with a bead multiplex assay (eBioscience)
according to the manufacturer’s instructions and murine cytokine
levels (IL-6, IL-10) with ELISA kits (R&D Systems, Minneapolis, MN).
Statistical analysis
Statistical data were analyzed using Prism 6.00 for Windows
(GraphPad Software, La Jolla, CA). In vivo data were analyzed using
Mann-Whitney test for 2-group comparison, Dunn’s multiple
comparison test for 3-group comparison, and log-rank test for
survival analysis. In vitro data were analyzed using 2-tailed Student’s
t-test for paired samples.
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Supplementary Figure S1. CD11b is required for iC3b-mediated
effect on LPS-induced cytokine production by myeloid cells. (A) Day 7Kidney International (2016) 89, 823–832BM-derived macrophages from wild-type or Itgam–/– mice were
preincubated with iC3b-gRBCs for 1 hour prior to LPS stimulation
(10 ng/ml). The amounts of IL-6 and IL-10 were measured by ELISA 24
hours later. The cytokine changes between the samples with and
without CR3 pre-engagement with iC3b are shown with the P values
indicated. Data represent mean  SEM (n ¼ 3). (B) Histograms
showing cell surface expression of CD11b on human monocytes and
monocyte-derived macrophages at day 2 and day 7 during in vitro
culture. The expression was assessed by ﬂow cytometry using 2 an-
tibodies: ICRF44 and CBRM1/5 (active state). The data are represen-
tative of 2 independent experiments.
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